We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.32B
1-Year Est. Return 16.01%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$424M
AUM Growth
-$8.4M
Cap. Flow
-$13.2M
Cap. Flow %
-3.1%
Top 10 Hldgs %
42.34%
Holding
57
New
3
Increased
16
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$15.8M
2
NXPI icon
NXP Semiconductors
NXPI
+$13M
3
SONY icon
Sony
SONY
+$12.7M
4
CRL icon
Charles River Laboratories
CRL
+$7.24M
5
AMZN icon
Amazon
AMZN
+$1.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.37%
2 Technology 17.07%
3 Healthcare 11.67%
4 Communication Services 11.53%
5 Financials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$3.91T
$7.69M 1.81%
125,900
+6,500
+5% +$385K
MSFT icon
27
Microsoft
MSFT
$2.84T
$7.58M 1.79%
54,515
-1,700
-3% -$234K
AMZN icon
28
Amazon
AMZN
$2.5T
$6.44M 1.52%
74,200
+19,100
+35% +$1.77M
LEN icon
29
Lennar Class A
LEN
$20.4B
$4.91M 1.16%
90,723
-5,062
-5% -$247K
SPY icon
30
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$4.45M 1.05%
15,000
-12,000
-44% -$3.55M
IQV icon
31
IQVIA
IQV
$34.7B
$4.3M 1.01%
28,780
RUN icon
32
Sunrun
RUN
$2.37B
$4M 0.94%
239,409
-29,246
-11% -$511K
AYI icon
33
Acuity Brands
AYI
$9.88B
$3.32M 0.78%
24,610
-1,500
-6% -$195K
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.63M 0.38%
5,479
+330
+6% +$97.5K
ACWX icon
35
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$1.61M 0.38%
34,900
+6,400
+22% +$293K
MET icon
36
MetLife
MET
$61B
$1.26M 0.3%
26,800
-13,300
-33% -$634K
DIS icon
37
Walt Disney
DIS
$165B
$1.25M 0.3%
9,600
-5,200
-35% -$719K
APO icon
38
Apollo Global Management
APO
$70.7B
$1.21M 0.29%
32,000
-6,300
-16% -$229K
VICI icon
39
VICI Properties
VICI
$29.4B
$1.2M 0.28%
52,900
-10,000
-16% -$218K
APD icon
40
Air Products & Chemicals
APD
$66.3B
$1.13M 0.27%
5,100
-36,259
-88% -$8.16M
BALL icon
41
Ball Corp
BALL
$17B
$1.13M 0.27%
15,500
-2,700
-15% -$201K
PFE icon
42
Pfizer
PFE
$140B
$1.11M 0.26%
32,463
-7,800
-19% -$284K
RCL icon
43
Royal Caribbean
RCL
$78.7B
$1.04M 0.25%
9,600
-1,900
-17% -$209K
NSLR
44
Neostellar Capital Corp
NSLR
$262M
$1.04M 0.25%
198,517
CB icon
45
Chubb
CB
$140B
$1.03M 0.24%
6,400
-1,400
-18% -$217K
EQM
46
DELISTED
EQM Midstream Partners, LP
EQM
$1.03M 0.24%
31,500
-7,000
-18% -$246K
CWEN icon
47
Clearway Energy Class C
CWEN
$5B
$863K 0.2%
47,300
-14,000
-23% -$248K
RTN
48
DELISTED
Raytheon Company
RTN
$863K 0.2%
4,400
-5,500
-56% -$1.02M
VMC icon
49
Vulcan Materials
VMC
$36.3B
$817K 0.19%
5,400
-73,561
-93% -$10.4M
TIGO icon
50
Millicom
TIGO
$15.8B
$803K 0.19%
16,500
-8,670
-34% -$453K

Similar funds

M.D. Sass LLC's Q3 2019 Portfolio in Review

As of Q3 2019, M.D. Sass LLC held 57 positions worth $424M, down 1.9% from $432M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

M.D. Sass LLC withdrew a net $13.2M in Q3 2019, closing 4 positions and reducing 32 holdings. Its most notable exit was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.

Against the trend, M.D. Sass LLC opened a new position in Quest Diagnostics worth $16.5M.

  • M.D. Sass LLC's largest Q3 2019 buy was Quest Diagnostics: 154,057 shares worth $16.5M.
  • M.D. Sass LLC added most to Charles River Laboratories in Q3 2019, an estimated $7.24M increase.
  • M.D. Sass LLC's biggest Q3 2019 reduction was Vulcan Materials, cutting an estimated $10.4M.
  • M.D. Sass LLC fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q3 2019, selling an estimated $14.5M.
  • M.D. Sass LLC's ten largest holdings make up 42% of its $424M portfolio in Q3 2019.
  • M.D. Sass LLC opened 3 new positions and closed 4 in Q3 2019.
  • M.D. Sass LLC's portfolio value fell 1.9% quarter-over-quarter to $424M.

Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.